NEWS
- siRNA Drugs: Challenges and Opportunities
- Cyclic Peptides: Current Status & Future Prospects
- Nanobodies - Current Status and Prospects
- Targeted Therapies for Multiple Myeloma (MM)
- IL-6 Unveiled: From Inflammation to Breakthrough Therapeutics
- PEG‐rhG‐CSF for Neutropenia
- FRα Targeting ADCs for Ovarian cancer
- Cleavable & Non-Cleavable PEG Linkers for XDCs
- Emerging Multiple Myeloma Therapies: mAbs, ADCs, CAR-T Cells & Bispecific Antibodies
- Visit Us at PEGS Boston Summit 2023, Booth #212
